CN101167974B - 一种虚汗停制剂的定性定量检测方法 - Google Patents

一种虚汗停制剂的定性定量检测方法 Download PDF

Info

Publication number
CN101167974B
CN101167974B CN2007100310421A CN200710031042A CN101167974B CN 101167974 B CN101167974 B CN 101167974B CN 2007100310421 A CN2007100310421 A CN 2007100310421A CN 200710031042 A CN200710031042 A CN 200710031042A CN 101167974 B CN101167974 B CN 101167974B
Authority
CN
China
Prior art keywords
xuhanting
preparation
quality control
butyl alcohol
astragaloside
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN2007100310421A
Other languages
English (en)
Other versions
CN101167974A (zh
Inventor
黄夏敏
邓祝玲
刘声波
顾利红
林彤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GUANGZHOU BAIYUNSHAN QIXING PHARMACEUTICAL CO., LTD.
Original Assignee
QIXING PHARMACEUTICAL CO Ltd GUANGZHOU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by QIXING PHARMACEUTICAL CO Ltd GUANGZHOU filed Critical QIXING PHARMACEUTICAL CO Ltd GUANGZHOU
Priority to CN2007100310421A priority Critical patent/CN101167974B/zh
Publication of CN101167974A publication Critical patent/CN101167974A/zh
Application granted granted Critical
Publication of CN101167974B publication Critical patent/CN101167974B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

本发明公开了一种虚汗停制剂的定性定量检测方法,修订了原有虚汗停颗粒的质量控制标准,增加了黄芪甲苷的含量测定。本发明的虚汗停制剂的定性定量检测方法,阴性对照没有干扰,具有较强的专属性和良好的重现性,有利于实现对虚汗停制剂成品质量的有效控制,确保人体的用药的安全性和有效性。本发明既可以用于虚汗停颗粒的质量控制,用可以用于虚汗停胶囊剂、口服液等其他剂型的质量控制。

Description

一种虚汗停制剂的定性定量检测方法
技术领域
本发明涉及中药复方制剂的定性定量检测方法,具体地说涉及的是治疗自汗、盗汗药物虚汗停制剂的定性定量检测方法。
背景技术
虚汗停颗粒是一种治疗虚汗、盗汗、小儿盗汗临床应用疗效肯定的药物,已上市多年,由黄芪、浮小麦、大枣、糯稻根、牡蛎(煅)按中药颗粒剂常规工艺制备。该产品标准收载于《卫生部药品标准中药成方制剂》第十四册,标准号WS3-B-2776-97,现行标准中仅有黄芪的薄层色谱法定性鉴别项目,缺乏含量测定项目,不能反映出产品中黄芪的含量,未能全面控制药品质量。实际上,虚汗停制剂也可以加工成口服液、胶囊等其他剂型。
发明内容
本发明的目的就是为了克服现行标准中仅有的黄芪的定性鉴别项目、缺乏含量测定项目的缺点,提供一种既有定性检测、又有定量检测、能更有效地控制了产品的质量、确保产品的安全性和有效性的虚汗停制剂的定性定量检测方法。
本发明的技术方案是:在原虚汗停颗粒质量控制标准即黄芪的薄层色谱法定性鉴别的基础上增加用高效液相色谱法测定虚汗停颗粒中的黄芪甲苷含量,较佳的条件是:
(1)供试品溶液的制备取虚汗停制剂加水溶解,用水饱和的正丁醇振摇提取,正丁醇液用氨试液洗涤,再用正丁醇饱和水洗涤,正丁醇液蒸干,残渣加甲醇溶解,作为供试品溶液。
(2)对照品溶液的制备取黄芪甲苷加甲醇制成对照品溶液,浓度可为每1ml含0.5mg的溶液。
(3)色谱条件以十八烷基硅烷键合硅胶为填充剂;以乙腈-水(35∶65)为流动相;蒸发光散射检测器。

Claims (2)

1.一种虚汗停制剂的定性定量检测方法,包括黄芪的薄层色谱法定性鉴别方法,其特征在于,另采用高效液相色谱法测定虚汗停制剂中黄芪甲苷的含量:其条件为:
a.供试品溶液的制备取虚汗停制剂加水溶解,用水饱和的正丁醇振摇提取,正丁醇液用氨试液洗涤,再用正丁醇饱和水洗涤,正丁醇液蒸干,残渣加甲醇溶解,作为供试品溶液;
b.对照品溶液的制备取黄芪甲苷加甲醇制成对照品溶液;
c.色谱条件以十八烷基硅烷键合硅胶为填充剂,以乙腈-水35∶65为流动相,蒸发光散射检测器;
d.测定法取对照品溶液和供试品溶液注入液相色谱仪,测定,以外标两点法对数方程计算,即得。
2.根据权利要求1所述的的一种虚汗停颗粒的定性定量检测方法,其特征在于高效液相色谱柱理论板数按黄芪甲苷峰计算不低于3000。
CN2007100310421A 2007-10-24 2007-10-24 一种虚汗停制剂的定性定量检测方法 Active CN101167974B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2007100310421A CN101167974B (zh) 2007-10-24 2007-10-24 一种虚汗停制剂的定性定量检测方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2007100310421A CN101167974B (zh) 2007-10-24 2007-10-24 一种虚汗停制剂的定性定量检测方法

Publications (2)

Publication Number Publication Date
CN101167974A CN101167974A (zh) 2008-04-30
CN101167974B true CN101167974B (zh) 2011-01-26

Family

ID=39388824

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007100310421A Active CN101167974B (zh) 2007-10-24 2007-10-24 一种虚汗停制剂的定性定量检测方法

Country Status (1)

Country Link
CN (1) CN101167974B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101551365B (zh) * 2009-05-18 2013-01-16 郑州市协和制药厂 当归补血口服液中黄芪甲苷含量的测定方法
CN102247544B (zh) * 2010-05-18 2012-09-26 周国生 一种治疗盗汗的中药及其制备方法
CN101884745A (zh) * 2010-07-05 2010-11-17 王幺光 一种治疗自汗、盗汗的中药制剂

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
卫生部药品标准中药成方制剂 WS3-B-2776-97.1997,Z14-149.
卫生部药品标准中药成方制剂 WS3-B-2776-97.1997,Z14-149. *

Also Published As

Publication number Publication date
CN101167974A (zh) 2008-04-30

Similar Documents

Publication Publication Date Title
CN101011435A (zh) 一种山香圆叶提取物及其制备方法和医药用途
Yan et al. Discovery of anti-2019-nCoV agents from Chinese patent drugs via docking screening
CN101167974B (zh) 一种虚汗停制剂的定性定量检测方法
CN102038897A (zh) 中药制剂的质量控制方法
Feng et al. Pharmacokinetics study of bio-adhesive tablet of Panax notoginseng saponins
CN104161847A (zh) 一种治疗糖尿病视网膜病变的中药组合物的质量检测方法
CN1803180A (zh) 一种药物组合物及其制备方法和质量控制方法
CN102784275A (zh) 通滞苏润江片及其制备和质量控制方法
Elshanawane et al. Application of a validated, stability-indicating LC method to stress degradation studies of ramipril and moexipril. HCl
CN102836256A (zh) 一种白蒲黄片的制备方法
Gong et al. Pharmacokinetics of levosulpiride after single and multiple intramuscular administrations in healthy Chinese volunteers
CN101513456B (zh) 治疗头痛的中药组合物及其制备方法和质量控制方法
CN107432867A (zh) 一种托伐普坦片
CN103099862B (zh) 治疗风湿痹痛疾病的外用制剂及其制备方法和应用
CN102697932B (zh) 治疗皮肤瘙痒的药物组合物及质量检测方法
CN102872219B (zh) 一种清热泻火解毒化瘀凉血止血的药物组合物及制备方法
CN100358492C (zh) 治疗头痛的中药制剂及其制备方法
CN102552751A (zh) 一种儿宝膏的质量检测方法
Liang et al. Pharmacokinetic properties of S-oxiracetam after single and multiple intravenous infusions in healthy volunteers
CN102824487A (zh) 轻身减肥胶囊的制备方法
CN102406897B (zh) 一种醒脑静固体药物组合物的制备方法
CN101518519A (zh) 一种柚皮苷缓释片及其制备方法
CN103735689A (zh) 一种天然药物组合物在制备耐缺氧药品及保健品中的应用
CN100551373C (zh) 盐酸丁螺环酮缓/控释微丸
CN102759600A (zh) 苏菲咳糖浆的检测方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: GUANGZHOU BAIYUNSHAN QIXING PHARMACEUTICAL CO., LT

Free format text: FORMER NAME: QIXING PHARMACEUTICAL CO., LTD., GUANGZHOU

CP03 Change of name, title or address

Address after: 510310 Guangdong city of Guangzhou province Haizhuqu District Xingang road Chigang Road No. 33

Patentee after: GUANGZHOU BAIYUNSHAN QIXING PHARMACEUTICAL CO., LTD.

Address before: 510310 Guangdong Province, Guangzhou city Xingang road Chigang Road No. 33

Patentee before: Qixing Pharmaceutical Co., Ltd., Guangzhou